Real-world evidence of ocrelizumab in Chilean patients with multiple sclerosis.
Del Canto A, Cárcamo C, Garcia L, Aylwin E, Jürgensen-Heinrich L, Guzman-Carcamo I, de la Barra J, Gutierrez-Calquin L, Barrera-Hormazabal A, Cruz JP, Bravo S, Pelayo C, Soler B, Uribe-San-Martin R, Ciampi E.
Del Canto A, et al. Among authors: garcia l.
Mult Scler. 2025 Jan 6:13524585241309835. doi: 10.1177/13524585241309835. Online ahead of print.
Mult Scler. 2025.
PMID: 39757941